SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 840.01 |
| Enterprise Value ($M) | 863.69 |
| Book Value ($M) | 18.44 |
| Book Value / Share | 0.29 |
| Price / Book | 45.55 |
| NCAV ($M) | -57.47 |
| NCAV / Share | -0.92 |
| Price / NCAV | -14.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.41 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -8.63 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.96 |
| Current Ratio | 3.21 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 150.26 |
| Assets | 226.18 |
| Liabilities | 207.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 202.09 |
| Operating Income | -36.11 |
| Net Income | -61.69 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -34.01 |
| Cash from Investing | -1.63 |
| Cash from Financing | 44.64 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tang Capital Partners Lp | 5.40 | 1.93 | |
| 13G/A | Perceptive Advisors Llc | 6.90 | 28.41 | |
| 13G | Nantahala Capital Management, LLC | 5.10 | ||
| 13G | Vanguard Group Inc | 5.15 | ||
| 13G/A | Stonepine Capital Management, LLC | 9.30 | 27.36 | |
| 13G/A | First Manhattan Co | 0.86 | -88.69 | |
| 13G | BlackRock Inc. | 5.80 | 102.07 | |
| 13G/A | Medytox Inc. | 5.90 | -53.66 | |
| 13G/A | Flynn James E | 0.00 | -99.95 | |
| 13D/A | Alphaeon 1 LLC | -100.00 | ||
| 13G/A | Millennium Management Llc | 4.60 | -21.90 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 149,893 | 983,592 | 15.24 | |
| 67,241 | 451,716 | 14.89 | |
| 60,548 | 181,112 | 33.43 | |
| 168,465 | 1,126,051 | 14.96 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EGRX – Eagle Pharmaceuticals, Inc. | ELTX – Elicio Therapeutics, Inc. |
| ELYM – Eliem Therapeutics, Inc. | ESPR – Esperion Therapeutics, Inc. |
| ETNB – 89bio, Inc. |
Financial data and stock pages provided by
Fintel.io